Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening

被引:3
作者
Liebermann, Erica [1 ,2 ]
Fontenot, Holly B. [3 ]
Lim, Eunjung [4 ]
Matsunaga, Masako [4 ]
Zimet, Gregory [5 ]
Allen, Jennifer D. [6 ]
机构
[1] Univ Rhode Isl, Coll Nursing, RINEC, 350 Eddy St, Providence, RI 02903 USA
[2] Univ Rhode Isl, Coll Nursing, Providence, RI USA
[3] Univ Hawaii Manoa, Nancy Atmospera Walch Sch Nursing, Honolulu, HI USA
[4] Univ Hawaii Manoa, John A Burns Sch Med, Dept Quantitat Hlth Sci, Honolulu, HI USA
[5] Indiana Univ, Sch Med, Indianapolis, IN USA
[6] Tufts Univ, Sch Arts & Sci, Dept Community Hlth, Medford, MA USA
来源
JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING | 2023年 / 52卷 / 05期
关键词
HEALTH-CARE PROVIDERS; WOMEN; ACCEPTABILITY; PARTICIPATION; PERSPECTIVES;
D O I
10.1016/j.jogn.2023.05.114
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Objective: To examine associations among women's preferred locations for human papillomavirus (HPV) self-sampling in relation to their demographic, social, and health characteristics and their perceived benefits and concerns regarding this procedure.Design: Cross-sectional, descriptive survey.Setting: Online distribution between March 2022 and April 2022.Participants: People who were assigned female sex at birth and were eligible for cervical cancer screening (N = 367: cis-gender women, n = 364; another gender identity, n = 3).Methods: We used quota sampling to obtain a racially and ethnically diverse sample. We conducted bivariate analyses to examine differences in participants' preferred locations for HPV self-sampling by sociodemographic and health characteristics. We used a multinomial logistic regression model to examine the associations between preferred HPV self-sampling location, characteristics of participants, and perceived benefits and concerns regarding this procedure.Results: In our sample, 43% (n = 158) of participants preferred HPV self-sampling at the office of a health care provider, 50% (n = 182) preferred HPV self-sampling anywhere (office or home), and 7% (n = 27) did not feel comfortable with HPV self-sampling anywhere. Participants 39 to 45 years of age were more likely to prefer HPV self sampling anywhere (office or home) than participants 27 to 32 years of age, OR = 2.47, 95% confidence interval (CI) [1.21, 5.06]. Participants who preferred HPV self-sampling anywhere perceived greater benefit related to limited geographic access to a clinic compared to those who preferred office only, OR = 1.82, 95% CI [1.08, 3.07]. Participants who preferred HPV self-sampling anywhere had less concern related to performing the procedure accurately than those who preferred office only, OR = 0.44, 95% CI [0.31, 0.62].Conclusion: HPV self-sampling is an alternative strategy to increase cervical cancer screening. As providers consider implementation of HPV self-sampling, our findings suggest that office and home-based collection strategies should be considered to increase access to cervical cancer screening.
引用
收藏
页码:364 / 373
页数:10
相关论文
共 37 条
[31]   Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland [J].
Virtanen, Anni ;
Anttila, Ahti ;
Luostarinen, Tapio ;
Nieminen, Pekka .
INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (11) :2681-2687
[32]   European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination [J].
von Karsa, Lawrence ;
Arbyn, Marc ;
De Vuyst, Hugo ;
Dinner, Joakim ;
Dinner, Lena ;
Franceschi, Silvia ;
Patnick, Julietta ;
Ronco, Guglielmo ;
Segnan, Nereo ;
Suonio, Eero ;
Tornberg, Sven ;
Anttila, Ahti .
PAPILLOMAVIRUS RESEARCH, 2015, 1 :22-31
[33]   Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study [J].
Wikstrom, I. ;
Lindell, M. ;
Sanner, K. ;
Wilander, E. .
BRITISH JOURNAL OF CANCER, 2011, 105 (03) :337-339
[34]   Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment A Randomized Clinical Trial [J].
Winer, Rachel L. ;
Lin, John ;
Tiro, Jasmin A. ;
Miglioretti, Diana L. ;
Beatty, Tara ;
Gao, Hongyuan ;
Kimbel, Kilian ;
Thayer, Chris ;
Buist, Diana S. M. .
JAMA NETWORK OPEN, 2019, 2 (11)
[35]   Strategies to reach marginalized women for cervical cancer screening: A qualitative study of stakeholder perspectives [J].
Wood, B. ;
Lofters, A. ;
Vahabi, M. .
CURRENT ONCOLOGY, 2018, 25 (01) :E8-E16
[36]  
World Health Organization, 2021, WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention EB/OL. (2021-07-06) 2021-07-18, Vsecond
[37]   Perspectives from Healthcare Providers and Women about Completing Human Papillomavirus (HPV) Self-Testing at Home [J].
Zimmermann, B. J. ;
Katz, M. L. ;
Moore, D. ;
Paskett, E. D. ;
Reiter, P. L. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03) :560-560